Biomarker strategy for an inhibitor in bladder cancer

Discover how Tempus’ multimodal data analysis helped a biotech partner identify a key biomarker in bladder cancer. This data-driven strategy de-risked clinical development and supported a successful financing round.

May 27, 2026
Life Sciences
Case Study